In contrast to extracranial malignant rhabdoid tumors, which characteristically show homozygous deletions affecting the SMARCB1 region [8], C-terminal truncating mutations are frequent in ATRT and predominantly encountered in the molecular subgroup ATRT-TYR [20]. This evidence concerns the gene TYR and atypical teratoid rhabdoid tumor.